Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive
- PMID: 22067763
- DOI: 10.1016/j.contraception.2011.08.001
Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive
Abstract
Background: This study evaluated the impact of weight on efficacy during use of an extended oral contraceptive (OC).
Study design: Data were from a Phase 3 clinical trial evaluating the efficacy of a low-dose 91-day extended regimen of 100 mcg levonorgestrel/20 mcg ethinyl estradiol (LNG/EE; 84 days)+10 mcg EE (7 days) for the prevention of pregnancy. Crude pregnancy rates were calculated for weight and body mass index (BMI) deciles.
Results: Of the 1736 women in this analysis, 878 (50.6%) had a BMI greater than 25 kg/m2, and 770 (44.4%) were heavier than 70 kg. Pregnancies occurred in 36 women. Crude pregnancy rates were similar across weight and BMI deciles, with no discernable differences observed between deciles using either classification criterion.
Conclusions: No evidence of any reduction in the level of contraceptive efficacy was observed with this low-dose extended OC regimen in overweight and obese women.
Copyright © 2012. Published by Elsevier Inc.
Similar articles
-
Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.Contraception. 2009 Dec;80(6):504-11. doi: 10.1016/j.contraception.2009.05.128. Epub 2009 Aug 6. Contraception. 2009. PMID: 19913143 Clinical Trial.
-
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives.Contraception. 2009 Jun;79(6):424-7. doi: 10.1016/j.contraception.2008.12.013. Epub 2009 Mar 4. Contraception. 2009. PMID: 19442776 Clinical Trial.
-
Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.Contraception. 2014 Apr;89(4):299-306. doi: 10.1016/j.contraception.2014.01.013. Epub 2014 Jan 29. Contraception. 2014. PMID: 24576794 Clinical Trial.
-
Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.Contraception. 2009 May;79(5):350-5. doi: 10.1016/j.contraception.2008.11.011. Epub 2009 Jan 17. Contraception. 2009. PMID: 19341846
-
Postcoital contraception: present and future options.J Adolesc Health. 1995 Jan;16(1):6-11. doi: 10.1016/1054-139X(94)00055-J. J Adolesc Health. 1995. PMID: 7742340 Review.
Cited by
-
Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women.Am J Obstet Gynecol. 2012 Jul;207(1):39.e1-6. doi: 10.1016/j.ajog.2012.04.022. Epub 2012 Apr 28. Am J Obstet Gynecol. 2012. PMID: 22727346 Free PMC article. Clinical Trial.
-
Combined hormonal contraceptive (CHC) use among obese women and contraceptive effectiveness: a systematic review.Contraception. 2017 Feb;95(2):117-129. doi: 10.1016/j.contraception.2016.10.010. Epub 2016 Nov 4. Contraception. 2017. PMID: 27823942 Free PMC article. Review.
-
Contraceptive failures in overweight and obese combined hormonal contraceptive users.Obstet Gynecol. 2013 Mar;121(3):585-592. doi: 10.1097/AOG.0b013e31828317cc. Obstet Gynecol. 2013. PMID: 23635622 Free PMC article.
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article. Review.
-
The creeping Pearl: Why has the rate of contraceptive failure increased in clinical trials of combined hormonal contraceptive pills?Contraception. 2013 Nov;88(5):604-10. doi: 10.1016/j.contraception.2013.04.001. Epub 2013 Apr 11. Contraception. 2013. PMID: 23683581 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
